Eligible patients were aged ≥12 years with moderate or severe PER (ie, symptoms >4 days/week for >4 consecutive weeks) and were prescribed MP-AzeFlu (one spray/nostril twice a day; daily doses: azelastine hydrochloride 548 μg; fluticasone propionate 200 μg) according to the summary of product characteristics.6 AR diagnosis was verified by local standard practice (eg, skin prick test or serum immunoglobulin E measures) as in the real-world clinical practice. The decision to include a patient in the study was made independently from and after the decision to prescribe MP-AzeFlu nasal spray. Treatment for at least 6 weeks was considered necessary. All patients (and caregivers, for those aged <18 years) were required to provide written informed consent prior to participation in the study.
Protocol detail
MP-AzeFlu Efficacy in Perennial AR
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Azelastine hydrochloride
Diagnosis
Fluticasone propionate
Immunoglobulin e
Nasal spray
Patients
Serum
Skin test
Corresponding Organization :
Other organizations : Karolinska Institutet, Mylan (Germany)
Top 5 similar protocols
Variable analysis
independent variables
- Age (≥12 years)
- Moderate or severe PER (symptoms >4 days/week for >4 consecutive weeks)
- Prescribed MP-AzeFlu nasal spray (one spray/nostril twice a day; daily doses: azelastine hydrochloride 548 μg; fluticasone propionate 200 μg)
- Not explicitly mentioned
- AR diagnosis verified by local standard practice (e.g., skin prick test or serum immunoglobulin E measures)
- Treatment for at least 6 weeks
- No positive or negative controls explicitly mentioned
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
Sign up for free or login to display all annotations
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!